Invited Commentary on Preventive Anti-Migraine Therapy (PAMT)

被引：0
|
作者：
Sameer Jain
Stephen D Silberstein
机构：
[1] Pain Treatment Centers of America,
[2] Thomas Jefferson University,undefined
来源：
Current Treatment Options in Neurology | 2019年 / 21卷
关键词：
Migraine; CGRP monoclonal antibody; Migraine prevention; CGRP receptor; Fremanezumab; Erenumab; Galcanezumab ; New migraine treatments; Migraine prophylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Migraine is a chronic paroxysmal neurological disorder characterized by multiphase attacks of head pain and a myriad of neurological symptoms. Chronic migraine causes a great personal and societal burden. Many patients are poorly responsive to, or non-compliant with, conventional migraine preventive therapies. For this reason, physicians are constantly looking for effective migraine prevention strategies. The recent introduction of an innovative pharmacological class useful for migraine prevention, namely monoclonal antibodies towards calcitonin gene-related peptide or its receptors, opens a new, immense therapeutic scenario. In this commentary, the development and efficacy of this novel class of preventive anti-migraine therapy have been discussed and compared with the conventional therapies of migraine prevention.
引用
收藏
相关论文
共 50 条
  • [31] ANTI-MIGRAINE DRUGS IN DEVELOPMENT - ADVANCES IN SEROTONIN RECEPTOR PHARMACOLOGY
    HUMPHREY, PPA
    FENIUK, W
    PERREN, MJ
    [J]. HEADACHE, 1990, 30 : 12 - 16
  • [32] HUMAN-PLASMA LEVELS OF SOME ANTI-MIGRAINE DRUGS
    MEIER, J
    SCHREIER, E
    [J]. HEADACHE, 1976, 16 (03): : 96 - 104
  • [33] Correction to: Anti-migraine agents from an immunological point of view
    Mushref Bakri Assas
    [J]. Journal of Translational Medicine, 19
  • [34] Other Preventive Anti-Migraine Treatments: ACE Inhibitors, ARBs, Calcium Channel Blockers, Serotonin Antagonists, and NMDA Receptor Antagonists
    Rau, Jill C.
    Dodick, David W.
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (04)
  • [35] Preventive therapy in pediatric migraine
    Wasiewski, WW
    [J]. JOURNAL OF CHILD NEUROLOGY, 2001, 16 (02) : 71 - 78
  • [36] Anticonvulsants in preventive therapy of migraine
    Filatova, EG
    Klimov, MV
    [J]. ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2003, 103 (10): : 65 - 68
  • [37] Other Preventive Anti-Migraine Treatments: ACE Inhibitors, ARBs, Calcium Channel Blockers, Serotonin Antagonists, and NMDA Receptor Antagonists
    Jill C. Rau
    David W. Dodick
    [J]. Current Treatment Options in Neurology, 2019, 21
  • [38] Anti-migraine and anti-depression activities of Tianshu capsule by mediating Monoamine oxidase
    Sun, Xiaoping
    Zhu, Fangfang
    Zhou, Jun
    Chang, Xiujuan
    Li, Liang
    Hu, Hanfei
    Wang, Zhenzhong
    Xiao, Wei
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2018, 100 : 275 - 281
  • [39] Inhibition of gap junctional intercellular communication by an anti-migraine agent, flunarizine
    Yeo, Joo Hye
    Choi, Eun Ju
    Lee, Jinu
    [J]. PLOS ONE, 2019, 14 (09):
  • [40] The Influence of Metoclopramide on Trigeminovascular Nociception: Possible Anti-migraine Mechanism of Action
    Dolgorukova, Antonina
    Osipchuk, Anastasiia, V
    Murzina, Anna A.
    Sokolov, Alexey Y.
    [J]. NEUROSCIENCE, 2020, 425 : 123 - 133
12345